Key Metrics of Lexicon Pharmaceuticals
Revenue$1.2M▲ 766.2% YoYFY 2023
Operating income−$172M▼ 70.5% YoY
Net profit−$177M▼ 73.7% YoY
Shareholders' equity$93.1M
Market cap$659MLXRX · $1.48
Competitors10identified
About Lexicon Pharmaceuticals
Sectors
Company details
- Website
- lexpharma.com
- Listed
- Nasdaq: LXRX
Operational Areas of Lexicon Pharmaceuticals
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameLexicon Pharmaceuticals Inc.
TickerLXRX
ExchangeNasdaq
CountryUnited States
SEC CIK0001062822
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.lexpharma.com
US market & SEC filings
LXRX · Nasdaq · SEC CIK 0001062822
Last price · 31 Oct 2026
$1.48
−0.34%
Market cap$659M
P/E—On FY 2023 diluted EPS
Volume1,772,659
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States
LXRX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeThe Woodlands
GSTIN—
Email—
Websitehttp://www.lexpharma.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Lexicon Pharmaceuticals
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.